Is Uber Stock a Buy on the Dip?
Shares of Uber Technologies (NYSE:UBER) have been fading fast in…
Buy
62
EMR Quote, Financials, Valuation and Earnings
Last price:
$125.71
Seasonality move
:
1.76%
Day range:
$125.22 - $126.83
52-week range:
$91.65 - $134.85
Dividend yield:
1.66%
P/E ratio:
36.96x
P/S ratio:
4.15x
P/B ratio:
3.33x
Volume:
1.5M
Avg. volume:
3.1M
1-year change:
29.6%
Market cap:
$72.1B
Revenue:
$17.5B
EPS (TTM):
$3.42
Analysts' Opinion
-
Consensus RatingEmerson Electric has received a consensus rating of Buy. The company's average rating is a Buy based on 18 Buy ratings, 6 Hold ratings, and 1 Sell rating.
-
Price Target UpsideAccording to analysts' consensus price target of $140.37, Emerson Electric has an estimated upside of 11.07% from its current price of $126.39.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $105.00 representing 16.92% downside risk from its current price of $126.39.
Fair Value
-
According to the consensus of 25 analysts, Emerson Electric has 11.07% upside to fair value with a price target of $140.37 per share.
EMR vs. S&P 500
-
Over the past 5 trading days, Emerson Electric has overperformed the S&P 500 by 1.45% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Emerson Electric does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Emerson Electric has grown year-over-year revenues for 8 quarters straight. In the most recent quarter Emerson Electric reported revenues of $4.6B.
Earnings Growth
-
Emerson Electric has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Emerson Electric reported earnings per share of $1.73.
Enterprise value:
82B
EV / Invested capital:
2.33x
Price / LTM sales:
4.15x
EV / EBIT:
35.35x
EV / Revenue:
4.69x
PEG ratio (5yr expected):
0.04x
EV / Free cash flow:
28.16x
Price / Operating cash flow:
24.90x
Enterprise value / EBITDA:
20.46x
Gross Profit (TTM):
$8.9B
Return On Assets:
4.36%
Net Income Margin (TTM):
11.25%
Return On Equity:
7.34%
Return On Invested Capital:
5.42%
Operating Margin:
17.1%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $13.8B | $15.2B | $17.5B | $4.1B | $4.6B | |
| Gross Profit | $6.3B | $7.4B | $8.9B | $2B | $2.4B | |
| Operating Income | $2.4B | $2.8B | $2.7B | $773M | $790M | |
| EBITDA | $3.5B | $4.3B | $4B | $1.4B | $1.3B | |
| Diluted EPS | $5.41 | $22.92 | $3.42 | $1.29 | $1.73 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $8.8B | $8.4B | $8.5B | $13.8B | $10.2B | |
| Total Assets | $22.9B | $24.7B | $35.7B | $42.7B | $44.2B | |
| Current Liabilities | $5.8B | $6.2B | $7.8B | $5B | $5.7B | |
| Total Liabilities | $14.4B | $14.8B | $19.4B | $16.1B | $16.7B | |
| Total Equity | $8.4B | $9.9B | $16.3B | $26.6B | $27.5B | |
| Total Debt | $7.5B | $6.7B | $10.4B | $8.2B | $7.7B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $2.9B | $637M | $3.3B | -$643M | $1.1B | |
| Cash From Investing | -$5.3B | $12.4B | -$5.4B | -$685M | $3.2B | |
| Cash From Financing | $2B | -$6.8B | -$2.5B | -$521M | -$3B | |
| Free Cash Flow | $2.6B | $274M | $2.9B | -$812M | $916M | |
EMR
Sector
Market Cap
$72.1B
$770.7M
Price % of 52-Week High
93.73%
79.02%
Dividend Yield
1.66%
0%
Shareholder Yield
3.15%
2.31%
1-Year Price Total Return
29.6%
-1.97%
Beta (5-Year)
1.341
0.898
Dividend yield:
1.66%
Annualized payout:
$2.10
Payout ratio:
61.03%
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$125.46
200-day SMA
Buy
Level
$112.91
Bollinger Bands (100)
Buy
Level
102.71 - 125.85
Chaikin Money Flow
Buy
Level
529.9M
20-day SMA
Sell
Level
$129.31
Relative Strength Index (RSI14)
Sell
Level
48.69
ADX Line
Buy
Level
17.46
Williams %R
Neutral
Level
-58.2019
50-day SMA
Buy
Level
$123.38
MACD (12, 26)
Sell
Level
-0.17
25-day Aroon Oscillator
Sell
Level
-48
On Balance Volume
Neutral
Level
213M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (4.2183)
Buy
CA Score
(Annual)
Level (-0.1266)
Buy
Beneish M-Score
(Annual)
Level (-2.4455)
Buy
Momentum Score
Level (7)
Sell
Ohlson Score
Level (0.7557)
Buy
Piotroski F Score
(Annual)
Level (7)
Buy
Quality Ratio Score
Level (4)
Buy
Fundamental Score
Level (10)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Founded in 1890 as the first manufacturer of electric fans in North America, Emerson Electric has become a leading industrial automation player through the acquisition of established brands. Emerson organizes its business into seven segments that sell a wide range of automation software, power tools, and automation hardware such as valves, gauges, and switches. In recent years, Emerson divested its climate technology and consumer businesses to become more of a pure-play industrial automation company. The automation of a factory is an enticing long-term proposition for manufacturers, helping reduce accident rates and raise uptime and productivity.
Stock Forecast FAQ
In the current month, EMR has received 18 Buy ratings 6 Hold ratings, and 1 Sell ratings. The EMR average analyst price target in the past 3 months is $140.37.
-
Where Will Emerson Electric Stock Be In 1 Year?
According to analysts, the consensus estimate is that Emerson Electric share price will rise to $140.37 per share over the next 12 months.
-
What Do Analysts Say About Emerson Electric?
Analysts are divided on their view about Emerson Electric share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Emerson Electric is a Sell and believe this share price will drop from its current level to $105.00.
-
What Is Emerson Electric's Price Target?
The price target for Emerson Electric over the next 1-year time period is forecast to be $140.37 according to 25 Wall Street analysts, 18 of them rate the stock a Buy, 1 rates the stock a Sell, and 6 analysts rate the stock a Hold.
-
Is EMR A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Emerson Electric is a Buy. 18 of 25 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of EMR?
You can purchase shares of Emerson Electric via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Emerson Electric shares.
-
What Is The Emerson Electric Share Price Today?
Emerson Electric was last trading at $125.71 per share. This represents the most recent stock quote for Emerson Electric. Yesterday, Emerson Electric closed at $126.39 per share.
-
How To Buy Emerson Electric Stock Online?
In order to purchase Emerson Electric stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is AMD Stock an All-Time Buy?
Advanced Micro Devices (NASDAQ:AMD) is a high-growth AI stock that…
How High Will Airbnb Stock Go?
Airbnb, Inc. (NASDAQ:ABNB) share price has seen substantial turbulence over…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 43x
Buy
56
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 117x
Buy
57
Is MSFT Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Alerts
Buy
64
ARQQ alert for Dec 27
Arqit Quantum [ARQQ] is down 3.22% over the past day.
Buy
64
QMCO alert for Dec 27
Quantum [QMCO] is up 4.72% over the past day.
Buy
65
ALGS alert for Dec 27
Aligos Therapeutics [ALGS] is down 4.82% over the past day.
